Back to Search
ERIC TOPOL, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1487723714IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G43112(CA)
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1979
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Genetic susceptibility to myocardial infarction and coronary artery disease.
PMID 16987874·Hum Mol Genet·2006
6-review
Simon Dack Lecture. The genomic basis of myocardial infarction.
PMID 16226168·J Am Coll Cardiol·2005
8-other
A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: factoring in new trials and meta-analysis data.
PMID 16124950·Am Heart J·2005
8-other
The rudimentary phase of personalised medicine: coronary risk scores.
PMID 14654312·Lancet·2003
8-other
Current status and future prospects for acute myocardial infarction therapy.
PMID 14605014·Circulation·2003
6-review
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
PMID 12874182·Circulation·2003
3-trial
Regionalization of care for acute ischemic heart disease: a call for specialized centers.
PMID 12654599·Circulation·2003
6-review
A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes.
PMID 12644350·J Am Coll Cardiol·2003
6-review
Economics and quality of care for patients with acute coronary syndromes: the impending crisis.
PMID 12428814·Clin Cardiol·2002
6-review
Recent advances in anticoagulant therapy for acute coronary syndromes.
PMID 11479487·Am Heart J·2001
6-review
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
PMID 11419425·N Engl J Med·2001
3-trial
The role of bivalirudin in percutaneous coronary intervention.
PMID 11156726·J Invasive Cardiol·2000
6-review
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
PMID 10827369·Am Heart J·2000
3-trial
Inflammation and embolization in ischemic heart disease.
PMID 10731293·J Invasive Cardiol·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10666 N TORREY PINES RD
LA JOLLA, CA 92037 - Phone
- (858) 554-5757
Quick Facts
- NPI
- 1487723714
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile